Vice President
Nantucket, Massachusetts, United States
AccessDX/MedTek21 is a real-time population health and medication risk management platform that brings personalized drug-to-gene monitoring to every patient. Our software-based platform works alongside existing medical record systems to continuously monitor and proactively identify patients for potential medication risks. Customizable alert engines, mobile-first workflows, API connectivity, and robust reporting enable better real time decision making throughout the entire care delivery ecosystem. MedTek21 is being used to positively impact outcomes for patients across long term care, home health, hospitals, ACOs, and PBMs.Earlier this year AccessDx responded to our clients' needs during the pandemic and delivered a turn-key COVID solution of a high-quality clinical grade RT-PCR test, guaranteed 24-48 response time and reporting to state agencies.